-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
June 01, 2014 - symptoms compared with patients receiving traditional in-
person therapy sessions. … symptoms and suicidal ideations within 40 minutes compared with
placebo. … symptoms were randomly assigned to complete SPARX or standard in-person behavioral
therapy. … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms with
an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
December 01, 2014 - symptoms compared with symptoms of patients receiving
traditional in-person therapy sessions. … symptoms and
suicidal ideations within 40 minutes compared with placebo. … , potentially restoring normal emotional processing and easing depressive symptoms.69
Clinical data … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
June 01, 2015 - For many patients, single ketamine doses often reduce depressive symptoms
within 2 hours, with improvements … symptoms within a few
hours or days, exponentially faster than many approved antidepressants.12,13 … symptoms and suicidal ideation within 40
minutes compared with placebo. … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in
ECT-resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
October 01, 2014 - believe that dysfunction in glutamate
neurotransmission may play a major role in the etiology of depressive … symptoms in both bipolar
disorder and MDD, although its exact mechanism of action is still unknown … symptoms
improved both significantly and rapidly and that these effects lasted from 3 days to several … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
January 01, 2012 - believe that dysfunction in glutamate neurotransmission may play a major
role in the etiology of depressive … symptoms in both bipolar disorder and MDD, although its exact
mechanism of action is still unknown … symptoms
improved both significantly and rapidly and that these effects lasted from 3 days to several … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms with
an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - believe that dysfunction in glutamate neurotransmission may play a major
role in the etiology of depressive … symptoms in both bipolar disorder and MDD, although its exact
mechanism of action is still unknown … symptoms improved both significantly and rapidly, and that these effects lasted from three days to … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
December 01, 2015 - and the severity of certain depressive
symptoms. … antidepressant, partly due to a
hypothesized link between dysfunctional glutamate neurotransmission and depressive … symptoms
observed in BPD and MDD.4
Preclinical studies indicate that ketamine’s antidepressant properties … Rapid decrease in depressive symptoms
with an N-methyl-d-aspartate antagonist in
ECT-resistant major … depression.
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - Researchers believe that dysfunctional glutamate
neurotransmission may play a major role in causing depressive … symptoms in both BPD and MDD,
although its exact mechanism of action is still unknown.59,61 Studies … symptoms improved both significantly and rapidly and that these effects
lasted from 3 days to several … Course of improvement in depressive
symptoms to a single intravenous infusion of
ketamine vs add-on … Rapid decrease in depressive symptoms with
an N-methyl-d-aspartate antagonist in ECT-
resistant major
-
effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
October 01, 2014 - believe that dysfunction in glutamate neurotransmission could play a major role in the
etiology of depressive … symptoms, although its exact mechanism of action is still unknown.
24
Research
suggests that N-methyl-D-aspartate … , investigators concluded, “Within 40 minutes, depressive symptoms
significantly improved in subjects … Deep brain stimulation for
treatment-resistant depression. … depression.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
January 30, 2014 - "
Depression"Scale"scores"(HADS)"(treatment"M=10.63"[2.67]h"waitlist"M=9.56"[3.09])"suggest"
that"participants"experienced"mildKtoKmoderate"depressive"symptoms … $symptoms$(CES"D$M=16$[mild$
depression]S$n=67)$found$a$significant$
reduction$in$depressive$symptoms … $and$anxiety$and$reducing$depressive$symptoms. … $symptoms$
(CES"D$M=16$[mild$
depression]S$n=67)$found$a$
significant$reduction$in$
depressive$symptoms … $Brain$morphometry$changes$and$
depressive$symptoms$after$traumatic$brain$injury.$Psychiatry!
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
March 29, 2013 - Refinements of note include:
• Population: We clarified that the scope includes treatment of subthreshold depressive … symptoms and added treatment during the time of conception. … • Subthreshold depressive symptoms which have become the subject of clinical attention. … Speed and duration of response/remission
o Relapse
o Recurrence
o Change in core depressive symptoms … Prevalence of mood symptoms and depressions during pregnancy:
implications for clinical practice and
-
effectivehealthcare.ahrq.gov/health-topics/depression/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_executive.pdf
April 01, 2012 - symptoms (a score
within the normal range of the symptom scale). … symptoms
are risk factors for relapse and negative predictors of
long-term outcome.22 Clinicians are … Depression and
diabetes: Impact of depressive symptoms on adherence,
function, and costs. … Relationship
between changes in depressive symptoms and unhealthy
lifestyles in late middle aged and … Depressive Symptoms
and clinical status during the treatment of adolescent suicide
attempters (TASA
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
May 01, 2013 - However, the
prevalence of depressive symptoms not meeting diagnostic
criteria for depression may be … symptoms. … symptoms
5 (8,071) Medium Consistent Direct Imprecise Low to moderate
SOE for reduced
number of … symptoms with
screening, there are limited data on other maternal or
infant health outcomes. … symptoms are substantially improved when screening,
diagnosis, and treatment are provided by the same
-
effectivehealthcare.ahrq.gov/products/depression-postpartum-screening/research
April 09, 2013 - Review Feb. 1, 2017 Disposition of Comments Report Efficacy and Safety of Screening for Postpartum Depression … Scale, 4 on the Postpartum Depression Screening Scale, 4 on different versions of the Beck Depression … Fifteen studies analyzed the association between risk factors and postpartum depression. … on five studies, there was low to moderate strength of evidence that screening resulted in decreased depressive … symptoms and improved mental health; in four of these studies, improvement in depressive symptoms was
-
effectivehealthcare.ahrq.gov/health-topics/depression-treatment
April 10, 2020 - Treatment of Depression in Children and Adolescents
Systematic Review
April 10, 2020 … Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults
Systematic … March 28, 2019
Adverse Effects of First-line Pharmacologic Treatments of Major Depression
-
effectivehealthcare.ahrq.gov/health-topics/postpartum-depression/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
April 01, 2016 - symptoms after two or
more failed adequate trials? … symptoms after two or more failed
adequate trials? … symptoms. … symptoms after two or more failed adequate trials? … symptoms after two or more failed adequate trials?
-
effectivehealthcare.ahrq.gov/products/depression-pregnancy-postpartum/research-protocol
March 29, 2013 - Refinements of note include:
Population: We clarified that the scope includes treatment of subthreshold depressive … symptoms and added treatment during the time of conception. … Subthreshold depressive symptoms which have become the subject of clinical attention. … duration of response/remission
Relapse
Recurrence
Change in core depressive symptoms
Anxiety … Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-chronic-conditions-interventions_executive.pdf
August 01, 2012 - symptoms. … Associations
of depressive symptoms with gender, body mass index
and dyspnea in primary care COPD … Clinical and health services relationships between major
depression, depressive symptoms, and general … Enhanced
depression care for patients with acute coronary syndrome and
persistent depressive symptoms … risk factors and depressive symptoms in
community dwelling elders.